Science Explorer Back to mapMap
Discussion
Researcher · Kyoto Pharmaceutical University · Japan

Shigehiko Takegami

Shigehiko Takegami publishes mostly in Molecular Biology, Organic Chemistry and Spectroscopy, on topics such as Protein Interaction Studies and Fluorescence Analysis, Lipid Membrane Structure and Behavior and Analytical Chemistry and Sensors.

ORCID 0000-0003-2454-7660 OpenAlex
World rank
#7,272,029
of 7,710,434 ranked researchers
Rank in Japan
#333,393
of 383,136
Works
55
Citations
758
Citations per work
13.8
h-index
16
i10-index 21Top 46% in Molecular Biology
Shigehiko Takegami

What does Shigehiko Takegami research?

Shigehiko Takegami's work is mostly in Biochemistry, Genetics and Molecular Biology (30%), Chemistry (14%), Medicine (5%).

Everything else: 23 works · 41.9% of their workLife Sciences: 16 works · 29.7% of their workBiochemistry, Genetics and Molecular Biology: 16 works · 29.7% of their workMolecular Biology: 16 works · 29.7% of their workPhysical Sciences: 13 works · 23.3% of their workChemistry: 8 works · 14.5% of their workOrganic Chemistry: 5 works · 8.2% of their workSpectroscopy: 3 works · 6.3% of their workChemical Engineering: 2 works · 4.4% of their workBioengineering: 2 works · 4.4% of their workEngineering: 2 works · 4.4% of their workBiomedical Engineering: 2 works · 4.4% of their workHealth Sciences: 3 works · 5.1% of their workMedicine: 3 works · 5.1% of their workOncology: 3 works · 5.1% of their workTHEIR WORKShigehikoTakegami55works
Life Sciences30%Physical Sciences23%Health Sciences5%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else2341.9%
    1. Biochemistry, Genetics and Molecular Biology1629.7%
    1. Chemistry814.5%
    2. Chemical Engineering24.4%
    3. Engineering24.4%
    1. Medicine35.1%
  1. 1Molecular Biology30% of their works
  2. 2Organic Chemistry8% of their works
  3. 3Spectroscopy6% of their works
  4. 4Oncology5% of their works
  5. 5Biomedical Engineering4% of their works
  6. 6Bioengineering4% of their works

Research topics

Which keywords describe Shigehiko Takegami's research?

The keywords of their largest research topics: Protein Binding, Serum Albumin, Lipid Rafts, Membrane Lipids, Biosensors, Ionic Liquids, Self-Assembly and Detection.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Protein Binding161 topic
  2. Serum Albumin161 topic
  3. Lipid Rafts131 topic
  4. Membrane Lipids131 topic
  5. Biosensors122 topics
  6. Ionic Liquids112 topics
  7. Self-Assembly112 topics
  8. Detection71 topic
  9. Electrochemical71 topic
  10. Ion-Selective Electrodes71 topic
  11. Optical Sensors71 topic
  12. ATP-dependent Transporters61 topic
  13. Micelles61 topic
  14. Multidrug Resistance61 topic
  15. Surfactants61 topic
  16. DNA nanotechnology51 topic
  17. Molecularly Imprinted Polymers51 topic
  18. Solid-Phase Microextraction51 topic
  19. aptamers51 topic

Where does Shigehiko Takegami work?

Shigehiko Takegami's main affiliation in the publication record is Kyoto Pharmaceutical University, Japan.

How many publications and citations does Shigehiko Takegami have?

OpenAlex counts 55 works and 758 citations for Shigehiko Takegami, an h-index of 16, ranking #7,272,029 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Shigehiko Takegami. Posts are plain text and can be reported.